Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases

International Journal of Proteomics

Volumn 2015, Issue , 2015, Pages

  Kalantari, Shiva ^a   Jafari, Ameneh ^b   Moradpoor, Raheleh ^b   Ghasemi, Elmira ^b   Khalkhal, Ensieh ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; AFAMIN; ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA AMYLASE PANCREAS ISOENZYME; ANTITHROMBIN III; APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOPTOSIS INDUCING FACTOR; BIOLOGICAL MARKER; CADHERIN; CD59 ANTIGEN; CERULOPLASMIN; COLLAGEN TYPE 4; DEOXYRIBONUCLEASE I; EPHRIN RECEPTOR B4; FATTY ACID BINDING PROTEIN; FETUIN A; GELSOLIN; GLUTATHIONE TRANSFERASE; HAPTOGLOBIN; HERMES ANTIGEN; IBP7 PROTEIN; LIPOCORTIN 1; MXRA8 PROTEIN; PLASMINOGEN; PROTEOME; SEROTRANSFERRIN; TOMOREGULIN; UNCLASSIFIED DRUG; UROM PROTEIN;

ACUTE KIDNEY FAILURE; ANALYTIC METHOD; CAPILLARY ELECTROPHORESIS; DIABETIC NEPHROPATHY; DOWN REGULATION; FOCAL GLOMERULOSCLEROSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; MASS SPECTROMETRY; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEIN URINE LEVEL; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; URINALYSIS; URINE PROTEOMICS;

EID: 85036650699     PISSN: 20902166     EISSN: 20902174     Source Type: Journal    
DOI: 10.1155/2015/782798     Document Type: Review

References (135)

1. J. Adachi, C. Kumar, Y. Zhang, J. V. Olsen, and M. Mann, "The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins, " Genome Biology, vol. 7, article R80, 2006.
2. H. Husi, N. Stephens, A. Cronshaw et al., "Proteomic analysis of urinary upper gastrointestinal cancer markers, " PROTEOMICS-Clinical Applications, vol. 5, no. 5-6, pp. 289-299, 2011.
3. V. C. Wasinger, M. Zeng, and Y. Yau, "Current status and advances in quantitative proteomic mass spectrometry, " International Journal of Proteomics, vol. 2013, Article ID 180605, 12 pages, 2013.
4. D. M. Good, V. Thongboonkerd, J. Novak et al., "Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future, " Journal of Proteome Research, vol. 6, no. 12, pp. 4549-4555, 2007.
5. S. Cui, P. J. Verroust, S. K. Moestrup, and E. I. Christensen, "Megalin/gp330 mediates uptake of albumin in renal proximal tubule, " American Journal of Physiology-Renal Fluid and Electrolyte Physiology, vol. 271, no. 4, pp. F900-F907, 1996.
6. T. Pisitkun, R.-F. Shen, and M. A. Knepper, "Identification and proteomic profiling of exosomes in human urine, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 36, pp. 13368-13373, 2004.
7. A. Castagna, D. Cecconi, L. Sennels et al., "Exploring the hidden human urinary proteome via ligand library beads, " Journal of Proteome Research, vol. 4, no. 6, pp. 1917-1930, 2005.
8. R. Pieper, C. L. Gatlin, A. M. McGrath et al., "Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots, " Proteomics, vol. 4, no. 4, pp. 1159-1174, 2004.
9. W. Sun, F. Li, S. Wu et al., "Human urine proteome analysis by three separation approaches, " Proteomics, vol. 5, no. 18, pp. 4994-5001, 2005.
10. L. Wang, F. Li, W. Sun et al., "Concanavalin A-captured glycoproteins in healthy human urine, " Molecular and Cellular Proteomics, vol. 5, no. 3, pp. 560-562, 2006.
11. M. Ozgo, W. F. Skrzypczak, A. Herosimczyk, and A. Mazur, "Proteomika a fizjologia i patofizjologia nerek, " MedWet, vol. 63, pp. 1146-1150, 2007.
12. B. Haraldsson and J. Sörensson, "Why do we not all have proteinuria An update of our current understanding of the glomerular barrier, " News in Physiological Sciences, vol. 19, no. 1, pp. 7-10, 2004.
13. A. B. Maunsbach, "Absorption of I125-labeled homologous albumin by rat kidney proximal tubule cells. A study of microperfused single proximal tubules by electron microscopic autoradiography and histochemistry, 1966, " Journal of theAmerican Society of Nephrology, vol. 8, no. 2, pp. 323-351, 1997.
14. M. J. Burne, T. M. Osicka, and W. D. Comper, "Fractional clearance of high molecular weight proteins in conscious rats using a continuous infusionmethod, " Kidney International, vol. 55, no. 1, pp. 261-270, 1999.
15. V. Batuman, P. J. Verroust, G. L. Navar et al., "Myeloma light chains are ligands for cubilin (gp280), " American Journal of Physiology-Renal Physiology, vol. 275, no. 2, pp. F246-F254, 1998.
16. E. I. Christensen and J. Gburek, "Protein reabsorption in renal proximal tubule-function and dysfunction in kidney pathophysiology, " Pediatric Nephrology, vol. 19, no. 7, pp. 714-721, 2004.
17. M. Afkarian, M. Bhasin, S. T. Dillon et al., "Optimizing a proteomics platform for urine biomarker discovery, " Molecular and Cellular Proteomics, vol. 9, no. 10, pp. 2195-2204, 2010.
18. J. Peng and S. P. Gygi, "Proteomics: the move to mixtures, " Journal ofMass Spectrometry, vol. 36, no. 10, pp. 1083-1091, 2001.
19. V. Thongboonkerd, "Proteomics in nephrology: current status and future directions, " American Journal of Nephrology, vol. 24, no. 3, pp. 360-378, 2004.
20. A. Marimuthu, R. N. O'Meally, R. Chaerkady et al., "A comprehensive map of the human urinary proteome, " Journal of Proteome Research, vol. 10, no. 6, pp. 2734-2743, 2011.
21. Q.-R. Li, K.-X. Fan, R.-X. Li et al., "A comprehensive and non?prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine, " Rapid Communications in Mass Spectrometry, vol. 24, no. 6, pp. 823-832, 2010.
22. P. A. Gonzales, T. Pisitkun, J. D. Hoffert et al., "Large-scale proteomics and phosphoproteomics of urinary exosomes, " Journal of the American Society ofNephrology, vol. 20, no. 2, pp. 363-379, 2009.
23. A. Khan and N. H. Packer, "Simple urinary sample preparation for proteomic analysis, " Journal of Proteome Research, vol. 5, no. 10, pp. 2824-2838, 2006.
24. V. Thongboonkerd, S. Chutipongtanate, and R. Kanlaya, "Systematic evaluationof sample preparationmethods for gel-based human urinary proteomics: quantity, quality, and variability, " Journal of Proteome Research, vol. 5, no. 1, pp. 183-191, 2006.
25. G. Gopalan, V. S. Rao, and V. V. Kakar, "An overview of urinary proteomics applications in human diseases, " International Journal of HighThroughput Screening, vol. 1, pp. 183-192, 2010.
26. H.-Y. Tang, L. A. Beer, and D. W. Speicher, "In-depth analysis of a plasma or serum proteome using a 4D protein profiling method, "Methods inMolecular Biology, vol. 728, pp. 47-67, 2011.
27. N. S. Vasudev, R. E. Ferguson, D. A. Cairns, A. J. Stanley, P. J. Selby, and R. E. Banks, "Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?" Proteomics, vol. 8, no. 23-24, pp. 5074-5085, 2008.
28. C.-L. Chen, T.-S. Lin, C.-H. Tsai et al., "Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics, " Journal of Proteomics, vol. 85, pp. 28-43, 2013.
29. S. Filip, K. Vougas, J. Zoidakis et al., "Comparison of depletion strategies for the enrichment of low-abundance proteins in urine, " PLoS ONE, vol. 10, no. 7, Article IDe0133773, 2015.
30. C.-M. Lu, Y.-J. Wu, C.-C. Chen et al., "Identification of lowabundance proteins via fractionation of the urine proteome with weak anion exchange chromatography, " Proteome Science, vol. 9, article 17, 2011.
31. S. A. Beausoleil, M. Jedrychowski, D. Schwartz et al., "Largescale characterization of HeLa cell nuclear phosphoproteins, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 33, pp. 12130-12135, 2004.
32. V. Thongboonkerd, T. Semangoen, and S. Chutipongtanate, "Enrichment of the basic/cationic urinary proteome using ion exchange chromatography and batch adsorption, " Journal of Proteome Research, vol. 6, no. 3, pp. 1209-1214, 2007.
33. M. M. Kushnir, P. Mrozinski, A. L. Rockwood, and D. K. Crockett, "A depletion strategy for improved detection of human proteins from urine, " Journal of Biomolecular Techniques, vol. 20, no. 2, pp. 101-108, 2009.
34. V. Thongboonkerd, "Current status of renal and urinary proteomics: ready for routine clinical application, " Nephrology Dialysis Transplantation, vol. 25, no. 1, pp. 11-16, 2010.
35. S. Decramer, A. G. de Peredo, B. Breuil et al., "Urine in clinical proteomics, "Molecular and Cellular Proteomics, vol. 7, no. 10, pp. 1850-1862, 2008.
36. J. Jia and L. Zhang, "Advance in proteomics research and application, " Journal of Animal and Veterinary Advances, vol. 11, no. 20, pp. 3812-3817, 2012.
37. H. Dihazi, "The urinary proteomics: a tool to discover new and potent biomarkers for kidney damage, " Journal of the International Federation of Clinical Chemistry and Laboratory Medicine, vol. 20, no. 1, pp. 82-91, 2009.
38. J. M. González-Buitrago, L. Ferreira, and I. Lorenzo, "Urinary proteomics, " Clinica Chimica Acta, vol. 375, no. 1-2, pp. 49-56, 2007.
39. M. M. Camacho-Carvcajal, B. Wollscheid, R. Aebersold, V. Steimle, and W. W. A. Schamel, "Two-dimensional Blue Native/SDS gel electrophoresiss of multi-protein complexes from whole cellular lysates: a proteomics approach, " Molecular and Cellular Proteomics, vol. 3, no. 2, pp. 176-182, 2004.
40. I. Neverova and J. E. Van Eyk, "Role of chromatographic techniques in proteomic analysis, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 815, no. 1-2, pp. 51-63, 2005.
41. T. Niwa, "Biomarker discovery for kidney diseases by mass spectrometry, " Journal of Chromatography B, vol. 870, no. 2, pp. 148-153, 2008.
42. M. G. Janech, J. R. Raymond, and J. M. Arthur, "Proteomics in renal research, " The American Journal of Physiology-Renal Physiology, vol. 292, no. 2, pp. F501-F512, 2007.
43. P. Rossing, "The changing epidemiology of diabetic microangiopathy in type 1 diabetes, " Diabetologia, vol. 48, no. 8, pp. 1439-1444, 2005.
44. G. Soldatos and M. E. Cooper, "Diabetic nephropathy: important pathophysiologic mechanisms, " Diabetes Research and Clinical Practice, vol. 82, no. 1, pp. S75-S79, 2008.
45. A. Soggiu, C. Piras, L. Bonizzi, H. A. Hussein, S. Pisanu, and P. Roncada, "A discovery-phase urine proteomics investigation in type 1 diabetes, " Acta Diabetologica, vol. 49, no. 6, pp. 453-464, 2012.
46. S. Kalantari, D. Rutishauser, S. Samavat et al., "Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography, " PLoS ONE, vol. 8, no. 12, Article IDe80830, 2013.
47. B. Xin, D. Pu, S. X. Xiong, and G. H. Wang, "On-line separation and detection of peptides by capillary electrophoresis/ electrospray FT-ICR-MS, " Chinese Chemical Letters, vol. 14, pp. 191-194, 2003.
48. D. Fliser, J. Novak, V. Thongboonkerd et al., "Advances in urinary proteome analysis and biomarker discovery, " Journal of the American Society of Nephrology, vol. 18, no. 4, pp. 1057-1071, 2007.
49. Z. Liu, Z. Yuan, and Q. Zhao, "SELDI-TOF-MS proteomic profiling of serum, urine, and amniotic fluid in neural tube defects, " PLoS ONE, vol. 9, no. 7, Article ID e103276, 2014.
50. J. Siwy, A. Vlahou, L. U. Zimmerli, P. Zürbig, and E. Schiffer, "Clinical proteomics: current techniques and potential applications in the elderly, " Maturitas, vol. 68, no. 3, pp. 233-244, 2011.
51. H. Mischak, E. Schiffer, P. Zürbig, M. Dakna, and J. Metzger, "Urinary proteome analysis using capillary electrophoresis coupled to mass spectrometry: a powerful tool in clinical diagnosis, prognosis and therapy evaluation, " Journal ofMedical Biochemistry, vol. 28, no. 4, pp. 223-234, 2009.
52. G. A. Müller, C. A. Müller, and H. Dihazi, "Clinical proteomics-on the long way from bench to bedside?" Nephrology Dialysis Transplantation, vol. 22, no. 5, pp. 1297-1300, 2007.
53. A. Albalat, H. Mischak, and W. Mullen, "Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation, " Prilozi, vol. 32, pp. 44-45, 2011.
54. M. M. Nilsen, K.-E. Uleberg, E. A. M. Janssen, J. P. A. Baak, O. K. Andersen, and A. Hjelle, "From SELDI-TOF MS to protein identification by on-chip elution, " Journal of Proteomics, vol. 74, no. 12, pp. 2995-2998, 2011.
55. C. Ibáñez, C. Simó, V. Garca-Cañas, A. Cifuentes, and M. Castro-Puyana, "Metabolomics, peptidomics and proteomics applications of capillary electrophoresis-mass spectrometry in Foodomics: a review, " Analytica Chimica Acta, vol. 802, pp. 1-13, 2013.
56. H. Mischak, J. J. Coon, J. Novak, E. M. Weissinger, J. P. Schanstra, and A. F. Dominiczak, "Capillary electrophoresismass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments, " Mass Spectrometry Reviews, vol. 28, no. 5, pp. 703-724, 2009.
57. J. Wu, Y.-D. Chen, andW. Gu, "Urinary proteomics as a novel tool for biomarker discovery in kidney diseases, " Journal of Zhejiang University: Science B, vol. 11, no. 4, pp. 227-237, 2010.
58. C. Simó, A. Cifuentes, and V. Kasicka, "Capillary electrophoresis-mass spectrometry for peptide analysis: targetbased approaches and proteomics/ peptidomics strategies, " Methods in Molecular Biology, vol. 984, pp. 139-151, 2013.
59. S. Hu, J. A. Loo, andD. T. Wong, "Human body fluid proteome analysis, " Proteomics, vol. 6, no. 23, pp. 6326-6353, 2006.
60. P. Dez, N. Dasilva, M. González-González et al., "Data analysis strategies for protein microarrays, " Microarrays, vol. 1, pp. 64-83, 2012.
61. R. Chen andM. Snyder, "Yeast proteomics and protein microarrays, " Journal of Proteomics, vol. 73, no. 11, pp. 2147-2157, 2010.
62. W. Ruige and Y. S. Fung, "Microfluidic chip-capillary electrophoresis device for the determination of urinary metabolites and proteins, " Bioanalysis, vol. 7, pp. 907-922, 2015.
63. W. P. Guo, Z. B. Rong, Y. H. Li, Y. S. Fung, G. Q. Gao, and Z. M. Cai, "Microfluidic chip capillary electrophoresis coupled with electrochemiluminescence for enantioseparation of racemic drugs using central composite design optimization, " Electrophoresis, vol. 34, no. 20-21, pp. 2962-2969, 2013.
64. C.-C. Lin, C.-C. Tseng, T.-K. Chuang, D.-S. Lee, and G.-B. Lee, "Urine analysis in microfluidic devices, " Analyst, vol. 136, no. 13, pp. 2669-2688, 2011.
65. J. R. Wísniewski, A. Zougman, N. Nagaraj, and M. Mann, "Universal sample preparation method for proteome analysis, " Nature Methods, vol. 6, no. 5, pp. 359-362, 2009.
66. Y. Yu, M.-J. Suh, P. Sikorski, K. Kwon, K. E. Nelson, and R. Pieper, "Urine sample preparation in 96-well filter plates for quantitative clinical proteomics, " Analytical Chemistry, vol. 86, no. 11, pp. 5470-5477, 2014.
67. Y. Lyutvinskiy, H. Yang, D. Rutishauser, and R. A. Zubarev, "In silico instrumental response correction improves precision of label-free proteomics and accuracy of proteomics-based predictive models, " Molecular and Cellular Proteomics, vol. 12, no. 8, pp. 2324-2331, 2013.
68. S. Samavat, S. Kalantari, M. Nafar et al., "Diagnostic urinary proteome profile for immunoglobulin a nephropathy, " Iranian Journal of Kidney Diseases, vol. 9, pp. 239-248, 2015.
69. S. Kalantari, M. Nafar, D. Rutishauser et al., "Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry andmultivariate statistical analysis, "BMCNephrology, vol. 15, no. 1, article 141, 2014.
70. S. Kalantari, M. Nafar, S. Samavat, M. Rezaei-Tavirani, D. Rutishauser, and R. Zubarev, "Urinary prognostic biomarkers in patients with focal segmental glomerulosclerosis, " Nephro-Urology Monthly, vol. 6, no. 2, Article ID e16806, 2014.
71. M. Nafar, S. Kalantari, S. Samavat, M. Rezaei-Tavirani, D. Rutishuser, and R. A. Zubarev, "The novel diagnostic biomarkers for focal segmental glomerulosclerosis, " International Journal of Nephrology, vol. 2014, Article ID 574261, 10 pages, 2014.
72. J. Cox, M. Y. Hein, C. A. Luber, I. Paron, N. Nagaraj, and M. Mann, "Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termedMaxLFQ, "Molecular and Cellular Proteomics, vol. 13, no. 9, pp. 2513-2526, 2014.
73. K. A. Neilson, N. A. Ali, S. Muralidharan et al., "Less label, more free: approaches in label-free quantitative mass spectrometry, " Proteomics, vol. 11, no. 4, pp. 535-553, 2011.
74. S. Nahnsen, C. Bielow, K. Reinert, and O. Kohlbacher, "Tools for label-free peptide quantification, " Molecular and Cellular Proteomics, vol. 12, no. 3, pp. 549-556, 2013.
75. L. Su, R. Zhou, C. Liu et al., "Urinary proteomics analysis for sepsis biomarkers with iTRAQ labeling and two-dimensional liquid chromatography-tandem mass spectrometry, " Journal of Trauma and Acute Care Surgery, vol. 74, no. 3, pp. 940-945, 2013.
76. M. T. Davis, C. S. Spahr, M. D. McGinley et al., "Towards defining the urinary proteome using liquid chromatographytandem mass spectrometry II. Limitations of complex mixture analyses, " Proteomics, vol. 1, no. 1, pp. 108-117, 2001.
77. H. Mischak, J. P. A. Ioannidis, A. Argiles et al., "Implementation of proteomic biomarkers: making it work, " European Journal of Clinical Investigation, vol. 42, no. 9, pp. 1027-1036, 2012.
78. B. Jim, M. Ghanta, A. Qipo et al., "Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study, " PLoS ONE, vol. 7, no. 5, Article ID e36041, 2012.
79. P. Zürbig, G. Jerums, P. Hovind et al., "Urinary proteomics for early diagnosis in diabetic nephropathy, " Diabetes, vol. 61, no. 12, pp. 3304-3313, 2012.
80. A. Lewandowicz, M. Bakun, R. Kohutnicki et al., "Changes in urine proteome accompanying diabetic nephropathy progression, " Polskie Archiwum Medycyny Wewnetrznej, vol. 125, pp. 27-38, 2015.
81. J. Barratt and J. Feehally, "IgA nephropathy, " Journal of the American Society of Nephrology, vol. 16, no. 7, pp. 2088-2097, 2005.
82. B. A. Julian, S. Wittke, M. Haubitz et al., "Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases, " World Journal of Urology, vol. 25, no. 5, pp. 467-476, 2007.
83. M. T. Rocchetti, M. Papale, A. M. d'Apollo et al., "Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy, " Clinical Journal of the American Society of Nephrology, vol. 8, no. 7, pp. 1115-1125, 2013.
84. B. A. Julian, S. Wittke, J. Novak et al., "Electrophoreticmethods for analysis of urinary polypeptides in lgA-associated renal diseases, " Electrophoresis, vol. 28, no. 23, pp. 4469-4483, 2007.
85. S. Zhao, R. Li, X. Cai et al., "The application of SILAC mouse in human body fluid proteomics analysis reveals protein patterns associated with IgA nephropathy, " Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 275390, 10 pages, 2013.
86. K. Mucha, M. Bakun, R. Jázwiec et al., "Complement components, proteolysis-related, and cell communication-related proteins detected in urine proteomics are associated with IgA nephropathy, " Polskie Archiwum Medycyny Wewnetrznej, vol. 124, no. 7-8, pp. 380-386, 2014.
87. V. D. D'Agati, F. J. Kaskel, and R. J. Falk, "Focal segmental glomerulosclerosis, "The New England Journal of Medicine, vol. 365, no. 25, pp. 2398-2411, 2011.
88. B. Bose and D. Cattran, "Glomerular diseases: FSGS, " Clinical Journal of the American Society of Nephrology, vol. 9, no. 3, pp. 626-632, 2014.
89. C. Kitiyakara, J. B. Kopp, and P. Eggers, "Trends in the epidemiology of focal segmental glomerulosclerosis, " Seminars in Nephrology, vol. 23, no. 2, pp. 172-182, 2003.
90. H.-A. Shui, T.-H. Huang, S.-M. Ka, P.-H. Chen, Y.-F. Lin, and A. Chen, "Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis, " Nephrology Dialysis Transplantation, vol. 23, no. 1, pp. 176-185, 2008.
91. R. P. Woroniecki, T. N. Orlova, N. Mendelev et al., "Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood, " American Journal of Nephrology, vol. 26, no. 3, pp. 258-267, 2006.
92. M. Zhao, M. Li, X. Li, C. Shao, J. Yin, and Y. Gao, "Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model, " Proteome Science, vol. 12, article 42, 2014.
93. T. Wu, C. Xie, H. W. Wang et al., "Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 inmultiplemurine lupus strains and human lupus nephritis, " Journal of Immunology, vol. 179, no. 10, pp. 7166-7175, 2007.
94. M. Suzuki, K. Wiers, E. B. Brooks et al., "Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis, " Pediatric Research, vol. 65, no. 5, pp. 530-536, 2009.
95. R. F. Rosa, K. Takei, N. C. Araújo, S. M. A. Loduca, J. C. M. Szajubok, and W. H. Chahade, "Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients, " The Journal of Rheumatology, vol. 39, no. 10, pp. 1948-1954, 2012.
96. Z. Xuejing, T. Jiazhen, L. Jun, X. Xiangqing, Y. Shuguang, and L. Fuyou, "Urinary TWEAK level as amarker of lupus nephritis activity in 46 cases, " Journal of Biomedicine and Biotechnology, vol. 2012, Article ID359647, 7 pages, 2012.
97. P. Lee, H. Peng, T. Gelbart, L. Wang, and E. Beutler, "Regulation of hepcidin transcription by interleukin-1 and interleukin-6, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 6, pp. 1906-1910, 2005.
98. K. Mosley, F. W. K. Tam, R. J. Edwards, J. Crozier, C. D. Pusey, and L. Lightstone, "Urinary proteomic profiles distinguish between active and inactive lupus nephritis, " Rheumatology, vol. 45, no. 12, pp. 1497-1504, 2006.
99. J. C. Oates, S. Varghese, A. M. Bland et al., "Prediction of urinary protein markers in lupus nephritis, " Kidney International, vol. 68, no. 6, pp. 2588-2592, 2005.
100. W. Sui, R. Zhang, J. Chen et al., "Comparative proteomic analysis of membranous nephropathy biopsy tissues using quantitative proteomics, " Experimental andTherapeuticMedicine, vol. 9, no. 3, pp. 805-810, 2015.
101. L. H. Beck Jr. and D. J. Salant, "Membranous nephropathy: forms models toman, " Journal of Clinical Investigation, vol. 124, no. 6, pp. 2307-2314, 2014.
102. L. H. Beck Jr. and D. J. Salant, "Membranous nephropathy: recent travels and new roads ahead, " Kidney International, vol. 77, no. 9, pp. 765-770, 2010.
103. H. H.-Y. Ngai, W.-H. Sit, P.-P. Jiang, R.-J. Xu, J. M.-F. Wan, and V. Thongboonkerd, "Serial changes in urinary proteome profile ofmembranous nephropathy: implications for pathophysiology and biomarker discovery, " Journal of Proteome Research, vol. 5, no. 11, pp. 3038-3047, 2006.
104. I. M. Rood, M. L. Merchant, D. W. Wilkey et al., "Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy, " Proteomics, vol. 15, no. 21, pp. 3722-3730, 2015.
105. P. Ruggenenti, C. Chiurchiu, V. Brusegan et al., "Rituximab in idiopathic membranous nephropathy: a one-year prospective study, " Journal of the American Society of Nephrology, vol. 14, no. 7, pp. 1851-1857, 2003.
106. M. V. Irazabal, A. Eirin, J. Lieske et al., "Low-and highmolecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study, " Nephrology Dialysis Transplantation, vol. 28, no. 1, pp. 137-146, 2013.
107. R. L. Mehta, J. A. Kellum, S. V. Shah et al., "Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury, " Critical Care, vol. 11, article R31, 2007.
108. S. Herget-Rosenthal, J. Metzger, A. Albalat, V. Bitsika, and H. Mischak, "Proteomic biomarkers for the early detection of acute kidney injury, " Prilozi, vol. 33, pp. 27-48, 2012.
109. M. T. Nguyen, G. F. Ross, C. L. Dent, and P. Devarajan, "Early prediction of acute renal injury using urinary proteomics, " American Journal of Nephrology, vol. 25, no. 4, pp. 318-326, 2005.
110. M. T. Nguyen, C. L. Dent, G. F. Ross et al., "Urinary aprotinin as a predictor of acute kidney injury after cardiac surgery in children receiving aprotinin therapy, " Pediatric Nephrology, vol. 23, no. 8, pp. 1317-1326, 2008.
111. J. Metzger, T. Kirsch, E. Schiffer et al., "Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury, " Kidney International, vol. 78, no. 12, pp. 1252-1262, 2010.
112. F. Aregger, C. Pilop, D. E. Uehlinger et al., "Urinary proteomics before and after extracorporeal circulation in patients with and without acute kidney injury, " Journal of Thoracic and Cardiovascular Surgery, vol. 139, no. 3, pp. 692-700, 2010.
113. F. Aregger, D. E. Uehlinger, J. Witowski et al., "Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury, " Kidney International, vol. 85, no. 4, pp. 909-919, 2014.
114. M. Bell, A. Larsson, P. Venge, R. Bellomo, and J. M?artensson, "Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury, " DiseaseMarkers, vol. 2015, Article ID 158658, 9 pages, 2015.
115. Y. Zhang, Y. Zhang, J. Adachi et al., "MAPU: max-planck unified database of organellar, cellular, tissue and body fluid proteomes, " Nucleic Acids Research, vol. 35, supplement 1, pp. D771-D779, 2007.
116. S.-J. Li, M. Peng, H. Li et al., "Sys-BodyFluid: a systematical database for human body fluid proteome research, " Nucleic Acids Research, vol. 37, supplement 1, pp. D907-D912, 2009.
117. J. Siwy, W. Mullen, I. Golovko, J. Franke, andP. Zürbig, "Human urinary peptide database formultiple disease biomarker discovery, " Proteomics-Clinical Applications, vol. 5, no. 5-6, pp. 367-374, 2011.
118. T. M. Shiju, V. Mohan, M. Balasubramanyam, and P. Viswanathan, "Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy, " Journal of Diabetes and its Complications, vol. 29, pp. 400-406, 2015.
119. J. Ma, X. Chen, J.-S. Li et al., "Upregulationofpodocyte-secreted angiopoietin-like-4 in diabetic nephropathy, " Endocrine, vol. 49, no. 2, pp. 373-384, 2014.
120. A. Caseiro, A. Barros, R. Ferreira et al., "Pursuing type 1 diabetes mellitus and related complications through urinary proteomics, " Translational Research, vol. 163, no. 3, pp. 188-199, 2014.
121. I. Zubiri, M. Posada-Ayala, A. Sanz-Maroto et al., "Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis, " Journal of Proteomics, vol. 96, pp. 92-102, 2014.
122. K. Inoue, J. Wada, J. Eguchi et al., "Urinary Fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray, " PLoS ONE, vol. 8, no. 10, Article ID e77118, 2013.
123. B. Surin, E. Sachon, J.-P. Rougier et al., "LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy, " Proteomics, vol. 13, no. 1, pp. 142-152, 2013.
124. J. Lopez-Hellin, C. Cantarell, L. Jimeno et al., "A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation, "American Journal of Transplantation, vol. 13, no. 2, pp. 493-500, 2013.
125. N. Piyaphanee, Q. Ma, O. Kremen et al., "Discovery and initial validation of 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome, " Proteomics-Clinical Applications, vol. 5, no. 5-6, pp. 334-342, 2011.
126. E. O. Honkanen, A.-M. Teppo, and C. Grönhagen-Riska, "Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis, " Kidney International, vol. 57, no. 6, pp. 2343-2349, 2000.
127. A. J. W. Branten, P. W. du Buf-Vereijken, I. S. Klasen et al., "Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study, " Journal of the American Society of Nephrology, vol. 16, no. 1, pp. 169-174, 2005.
128. T. Nakatsue, H. Koike, G. D. Han et al., "Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy, " Kidney International, vol. 67, no. 6, pp. 2239-2253, 2005.
129. C. R. Parikh, J. Mishra, H. Thiessen-Philbrook et al., "Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery, " Kidney International, vol. 70, no. 1, pp. 199-203, 2006.
130. W. K. Han, G. Wagener, Y. Zhu, S. Wang, and H. T. Lee, "Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery, " Clinical Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 873-882, 2009.
131. J. Mishra, C. Dent, R. Tarabishi et al., "Neutrophil gelatinaseassociated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery, " The Lancet, vol. 365, no. 9466, pp. 1231-1238, 2005.
132. V. S. Vaidya, V. Ramirez, T. Ichimura, N. A. Bobadilla, and J. V. Bonventre, "Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury, " The American Journal of Physiology-Renal Physiology, vol. 290, no. 2, pp. F517-F529, 2006.
133. G. Ramesh, C. D. Krawczeski, J. G. Woo, Y. Wang, and P. Devarajan, "Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery, " Clinical Journal of the American Society of Nephrology, vol. 5, no. 3, pp. 395-401, 2010.
134. P. Devarajan, C. D. Krawczeski, M. T. Nguyen, T. Kathman, Z. Wang, and C. R. Parikh, "Proteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children, " American Journal of Kidney Diseases, vol. 56, no. 4, pp. 632-642, 2010.
135. L. E. Morales-Buenrostro, O. I. Salas-Nolasco, J. Barrera-Chimal et al., "Hsp72 is a novel biomarker to predict acute kidney injury in critically ill patients, " PLoS ONE, vol. 9, no. 10, Article ID e109407, 2014.